期刊文献+

免疫荧光技术中不同固定剂对细胞p65核移位观察效果的影响 被引量:6

The effects of different fixing agents on the translocation of p65 protein by using immunofluorescence technique
下载PDF
导出
摘要 目的观察免疫荧光技术中不同固定剂以及Triton X-100不同渗透时间对小鼠腹腔巨噬细胞p65蛋白核移位的影响,找出最适合观察p65蛋白移位的固定方法及Triton X-100渗透时间。方法采用免疫荧光的方法观察使用不同固定剂(甲醇,1%~4%甲醛)固定,0.1%Triton X-100渗透3~15min的条件下,观察脂多糖刺激2h后,p65蛋白细胞内定位的情况。结果 p65蛋白在对照细胞主要定位于细胞质,脂多糖(LPS)刺激后p65蛋白移入胞核。甲醇固定后细胞荧光染色显色很弱且核区不明显,染色弥散;1%、2%甲醛固定不良可引起细胞收缩;4%甲醛固定后,核区与胞质p65蛋白荧光染色对比明显。0.1%Triton X-100作用3~5min效果最佳,而作用10~15min对照细胞核内也有较强荧光。结论本实验表明,在免疫荧光技术中采用4%甲醛固定20min,0.1%Triton X-100渗透3~5min可更好的观察LPS诱导的小鼠腹腔巨噬细胞p65核移位。 Objective To investigate the effects of different fixing agents and penetration duration time on the observation of p65 protein translocation, and to optimize the fixing and penetrating methods. Methods The translocation of p65 after stimulated by LPS was observed by using immunofluorescence technique. The effects of different fixing agents and various penetration duration of time on observation were compared. Results Untreated cells showed p65 in cytoplasm. LPS induced p65 translocation from cytoplasm to nuclear. P65 staining was much weaker when fixed by methanol. Four percent formaldehyde and 0.01 Triton X-100 penetrating 3-5 min gave the most distinguished staining between cytoplasm and nucleus. Conclusion Four percent formaldehyde and 0. 01 Triton 3:-100 penetrating 3-5 min are suitable for observing LPS induced p65 translocation by using immunofluorescence technique.
机构地区 汕头大学医学院
出处 《山西医药杂志(上半月)》 CAS 2012年第3期211-212,F0003,共3页 Shanxi Medical Journal
基金 国家自然科学基金(30870911)
关键词 免疫荧光测定 小鼠 巨噬细胞 Fluoroimmunoassay Mice Macrophages
  • 相关文献

参考文献9

  • 1Aggarwal BB.Nuclear factor-kappa B:the enemy within.Cancer Cell,2004,6(3):203-208.
  • 2Boyce BF,Yao Z,Xing L.Functions of nuclear factor kappa Bin bone.Ann NY Acad Sci,2010,1192:367-375.
  • 3Imanifooladi AA,Yazdani S,Nourani MR.The role of nuclearfactor-kappa B in inflammatory lung disease.Inflamm AllergyDrug Targets,2010,9(3):197-205.
  • 4Karin M.Nuclear factor-kappa B in cancer development andprogression.Nature,2006,441(7092):431-436.
  • 5Vermeulen L,de Wilde G,Notebaert S,et al.Regulation ofthe transcriptional activity of the nuclear factor-kappa B p65subunit.Biochem Pharmacol,2002,64(5-6):963-970.
  • 6Losick VP,Isberg RR.NF-κB translocation prevents host celldeath after low-dose chanllenge by Legionella pneumophila.JExp Med,2006,203(9):2177-2189.
  • 7蒲泽锦,吴灵飞.核因子-κB电泳迁移率变动分析方法的改进[J].汕头大学医学院学报,2005,18(3):169-171. 被引量:3
  • 8Khan N,Rahim SS,Boddupalli C,et al.Hydrogen peroxideinhibits IL-12p40induction in macrophages by inhibiting c-reltranslocation to the nucleus through activation of calmo-dulinprotein.Blood,2006,107:1513-1520.
  • 9秦犹,陈永昌.免疫荧光技术中不同固定剂对RhoA蛋白定位的影响[J].江苏大学学报(医学版),2006,16(5):385-388. 被引量:6

二级参考文献18

  • 1Onizuka T,Endo S,Hirano M,et al.Design of a fluorescent electrophoretic mobility shift assay improved for the quantitative and multiple analysis of protein-DNA complexes[J].Biosci Biotechnol Biochem,2002,66(12):2 732-2 734.
  • 2Jing D,Agnew J,Patton WF,et al.A sensitive two-color electrophoretic mobility shift assay for detecting both nucleic acids and protein in gels[J].Proteomics,2003,3(7):1 172-1 180.
  • 3Zerby D,Lieberman PM.Functional analysis of TFIID-activator interacti on by magnesium-agaros-e gel electrophoresis[J].Methods,1997,12(3):217-223.
  • 4Woo AJ,Dods JS,Susanto E,et al.A proteomics approach for the identification of DNA binding activities observed in the electrophoretic mobility shift assay[J].Mol Cell Proteomics,2002,1(6):472-478.
  • 5Yamamoto Y,Gaynor RB.Therapeutic potential of inhibition of the NF-κB path way in the treatment of inflammation and cancer[J].J Clin Invest,2001,107(2):135-142.
  • 6Roder K,Schweizer M.Running-buffer composition influen-ces DNA-protein and protein-protein complexes detected by electrophoretic mobility-shif tassay(EMSA)[J].Biotechnol Appl Biochem,2001,33(3):209-214.
  • 7Stebbins MA,Hoyt AM,Sepaniak MJ,et al.Design and optimization of a capillary electrophoretic mobility mobility shift assay involving trp repressor-DNA complexes[J].J Chromatogr B Biomed Appl,1996,683(1):77-84.
  • 8Laniel MA,Guerin SL.Improving sensitivity of the electrophoretic mobility shift assay by restricting tissue phosphatase activities[J].Biotechniques,1998,24(6):964-970.
  • 9Ronai Z,Wang Y,Khandurina J,et al.Transcription factor binding study by capillary zone electrophoretic mobility shift assay[J].Electrophoresis,2003,24(1~2):96-100.
  • 10Ruscher K,Reuter M,Kupper D,et al.A fluorescence based non-radioactive electrophoretic mobility shift assay[J].J Biotechnol,2000,78(2):163-170.

共引文献7

同被引文献59

  • 1秦犹,陈永昌.免疫荧光技术中不同固定剂对RhoA蛋白定位的影响[J].江苏大学学报(医学版),2006,16(5):385-388. 被引量:6
  • 2Tillman Vollbrandt,Dagmar Willkomm,Helge Stossberg,et al.Vigilin is co-localized with 80S ribosomes and binds to the ribosomal complex through its C-terminal domain[J].The International Journal of Biochemistry & Cell Biology,2004,36:1306-1318.
  • 3Jing Zhou,Qiaoqiao Wang,Ling-Ling Chen,et al.On the mechanism of induction of heterochro matin by the RNA-binding protein vigilin[J].RNA,2008,14:1773-1781.
  • 4Omar L.Kantidze,Olga V.Iarovaia,Elena S.Philonenko,et al.Unusual compartmentalization of CTCF and other transcription factors in the course of terminal erythroid differentiation[J].Biochim ica et Biophysica Acta,2007,1773:924-933.
  • 5Verónica Torrano,Joaquin Navascués,France Docquier,et al.Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly (ADP-ribosyl) ation-dependent mechanism[J].Journa 1 of Cell Science,2006,119:1746-1759.
  • 6Deanna DiDonato,Dawn L.Brasaemle Fixation Methods for the Study of Lipid Droplets by Im munofluorescence Microscopy[J].Journal of Histochemistry &Cytochemistry,2003,51 (6) ;773-780.
  • 7Berod A,Hartman BK,Pujol JF.Importance of fixation in immunohistochemistry:use of form aldehyde solutions at variable pH for the localization of tyrosine hydroxylase[J].Journal of Histoc hemistry & Cytochemistry,1981,29.844-850.
  • 8Paez J G, Janne P A, Lee J C, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy[J]. Science, 2004,304(5676): 1497.
  • 9Liang W, Zhang Y, Kang S, et al. Impact of EGFR mutation status on tumor response and progression free survival after first-line chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis[J]. J Thorac Dis, 2014,6(9): 1239.
  • 10Serrano M J, Ortega F G, Alvarez-Cubero M J, et al., EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer[J]. Oncotarget, 2014,5(17): 7486.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部